Roche
RO.SW
#32
Rank
$386.60 B
Marketcap
$485.22
Share price
0.25%
Change (1 day)
44.64%
Change (1 year)

EPS for Roche (RO.SW)

EPS in 2025: $20.44

According to Roche's latest financial reports the company's current EPS (TTM) is $20.44. In 2025 the company made an earnings per share (EPS) of $20.44 an increase over its 2024 EPS that were of $11.50.

EPS history for Roche from 1998 to 2025

Annual EPS

Year EPS Change
2025$20.4477.67%
2024$11.50-32.84%
2023$17.131.95%
2022$16.80-6.29%
2021$17.93-5.53%
2020$18.9816.56%
2019$16.2830.3%
2018$12.4920.22%
2017$10.39-5.81%
2016$11.034.62%
2015$10.55-5.13%
2014$11.12-25.05%
2013$14.8321.73%
2012$12.183.82%
2011$11.748.16%
2010$10.8523.72%
2009$8.77-12.31%
2008$10.00-0.34%
2007$10.0432.13%
2006$7.5942.56%
2005$5.33-22.7%
2004$6.89132.85%
2003$2.96-150.39%
2002-$5.87-209.09%
2001$5.38-57.03%
2000$12.5353.29%
1999$8.1731.24%
1998$6.23

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
$6.68-67.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$5.25-74.31%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$0.76-96.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$2.70-86.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$16.22-20.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$1.90-90.69%๐Ÿ‡ซ๐Ÿ‡ท France
Becton Dickinson
BDX
$3.60-82.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$0.99-95.14%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$2.88-85.92%๐Ÿ‡ฌ๐Ÿ‡ง UK